Immucell (ICCC) Free Cash Flow Growth (1y) (2011 - 2025)
Powered by 
Analysis
Immucell (ICCC) Free Cash Flow Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 112.68% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 17.21% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 35.56% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | -35.73% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -2.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 255.69% |
| Sep 30, 2025 | -144.11% |
| Jun 30, 2025 | 207.05% |
| Mar 31, 2025 | 257.54% |
| Dec 31, 2024 | 75.23% |
| Sep 30, 2024 | 21.60% |
| Jun 30, 2024 | 133.89% |
| Mar 31, 2024 | 110.11% |
| Dec 31, 2023 | 71.15% |
| Sep 30, 2023 | 53.41% |
| Jun 30, 2023 | -143.92% |
| Mar 31, 2023 | -1,938.43% |
| Dec 31, 2022 | -2,289.01% |
| Sep 30, 2022 | -378.46% |
| Jun 30, 2022 | -283.71% |
| Mar 31, 2022 | 82.63% |
| Dec 31, 2021 | 9.13% |
| Sep 30, 2021 | 80.55% |
| Jun 30, 2021 | -59.03% |
| Mar 31, 2021 | -146.49% |